Research and Development

Showing 15 posts of 9596 posts found.

World’s biggest DNA project launched

March 16, 2006 Research and Development DNA, MRC, UK Biobank, Wellcome

UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …

Deaths reported in dementia trial

March 16, 2006 Research and Development

Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …

Crestor hailed as first drug to reverse cardiovascular disease

March 14, 2006 Research and Development

Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …

Bright future for NicOx after Pfizer glaucoma deal

March 10, 2006 Research and Development

Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …

Wyeth to open clinical trial ‘Super Centres’

February 23, 2006 Research and Development

Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …

Pfizer’s new blood infection drug Eraxis approved

February 23, 2006 Research and Development

Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …

Tysabri trials restart after safety scare

February 20, 2006 Research and Development

Clinical trials of Tysabri, the troubled multiple sclerosis treatment, are to begin again in the US after the FDA gave …

Avastin trial recruitment suspended after patient deaths

February 16, 2006 Research and Development

Roche has stopped recruiting colon cancer patients who have undergone surgery to a trial of Avastin after four suddenly died.The …

Wyeth joins search for promising TLR drugs

February 15, 2006 Research and Development

A new collaboration between Wyeth and an Irish biotech company is to investigate the potential of 'toll like receptors', which …

GSK’s research chief leaves for Gates Foundation

February 9, 2006 Research and Development

GlaxoSmithKline's head of research and development Tachi Yamada is to leave the company, having been recruited by Bill Gates to …

Humira becomes Britain’s first biotech blockbuster

January 26, 2006 Research and Development

The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …

Amgen to expand R&D investment in UK

January 26, 2006 Research and Development

Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …

Roche and biotech swap roles in novel collaboration

January 24, 2006 Research and Development

Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006 Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …

FDA looks to streamline early research

January 19, 2006 Research and Development

The FDA has unveiled plans to allow more small-scale exploratory studies of drugs in humans before formal phase I studies …
The Gateway to Local Adoption Series

Latest content